Early Stage Venture Rappta Therapeutics Raises Series A of $10568701

October 12, 2020

About Rappta Therapeutics

Rappta Therapeutics is a lead-optimization stage biopharmaceutical company.

Website: Learn more on Rappta Therapeutics’s website

Crunchbase: Follow on Crunchbase

[adace-ad id=”4426″]

Series A – Rappta Therapeutics

Amount Raised9000000 EUR
Announced Date2020-10-13
Equity Only FundingYes
Organization LocationHelsinki, Southern Finland, Finland, Europe
Funding StatusEarly Stage Venture
Number of Funding Rounds1
Lead InvestorsNovartis Venture Fund, Novo Holdings
Number of Investors3
Number of Partner Investors3